key: cord-0948743-ayrg3ok3
authors: Sookaromdee, Pathum; Wiwanitkit, Viroj
title: New COVID-19 vaccines, its cost and shelf life: a cost effectiveness analysis
date: 2020-12-23
journal: Arch Med Res
DOI: 10.1016/j.arcmed.2020.12.008
sha: 301f479b06cf675f2d52585bbf04bb7c92f51ab6
doc_id: 948743
cord_uid: ayrg3ok3

nan

Dear Editor, the new COVID-19 vaccines become the hope for containing COVID-19 pandemic (1) (2) . As noted by Ita Here, the effectiveness is adjusted from reported efficacy according to shelf life and defined as "efficacy x shelf-life period in day". The final cost per effectiveness, cost-effectiveness value, is calculated. According to the analysis, the results are shown in Table 1 . According to the analysis, different cost-effectiveness values are derived, and this might be a good data for decision making for selection of appropriate new COVID-19 vaccine for usage in each setting. Nevertheless, the data on the safety and reported adverse effect of the vaccines must be continuously collected for further repeated reappraisal analysis after the post marketing real use.

J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f

COVID-19): Current Status and Prospects for Drug and Vaccine Development. Ita K

COVID-19 Vaccine Frontrunners and Their Nanotechnology Design

Developing a low-cost and accessible COVID-19 vaccine for global health